The two French companies said Tuesday that Kering would retain a 40% stake in the property and contribute the remaining 60% to a newly created joint venture with Ardian. The property on New York ...
A novel viral tool (FLEN) is designed, and used to monitor changes in the intrinsic and synaptic properties of engram cells quickly (3–6 hours) following encoding of a memory.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback